Reviva Pharmaceuticals Holdings reported net income of -$2.45M for the quarter ended Jun 2026. This income statement covers 33 quarters of results from May 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | May2018 | Aug2018 | Nov2018 | Feb2019 | May2019 | Aug2019 | Nov2019 | Feb2020 | May2020 | Aug2020 | Nov2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.92M | 0.72M | 0.76M | 0.92M | 1.02M | 1.02M | 1.02M | 1.13M | 1.03M | 1.40M | 1.40M | 1.49M | 1.67M | 1.66M | 2.34M | 2.49M | 3.63M | 3.63M | 7.02M | 13.11M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 1.42M | 2.66M | 5.83M | 4.51M | 4.24M | 7.42M | 5.48M | 8.26M | 9.57M | 8.11M | 5.78M | 5.58M | 6.86M | 4.68M | 4.11M | 3.72M | 2.13M | 1.74M | 1.44M | 1.39M | |||||||||||||
| Selling, General & AdministrativeSG&A | 1.05M | 1.30M | 1.62M | 1.01M | 1.26M | 1.48M | 1.50M | 3.08M | 1.99M | 1.51M | 2.14M | 2.55M | 1.60M | 1.60M | 2.42M | 2.35M | 1.90M | 1.82M | 1.84M | 1.22M | |||||||||||||
| Other Operating ExpensesOther Opex | |||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 2.48M | 3.96M | 7.45M | 5.52M | 5.50M | 8.89M | 6.98M | 11.34M | 11.56M | 9.62M | 7.92M | 8.13M | 8.46M | 6.28M | 6.54M | 6.07M | 4.03M | 3.56M | 3.27M | 2.62M | |||||||||||||
| Operating IncomeOp. Inc | -2.48M | -3.96M | -7.45M | -5.52M | -5.50M | -8.89M | -6.98M | -11.34M | -11.56M | -9.62M | -7.92M | -8.13M | -8.46M | -6.28M | -6.54M | -6.07M | -4.03M | -3.56M | -3.27M | -2.62M | |||||||||||||
| EBIT | -2.48M | -3.96M | -7.45M | -5.52M | -5.50M | -8.89M | -6.98M | -11.34M | -11.56M | -9.62M | -7.92M | -8.13M | -8.46M | -6.28M | -6.54M | -6.07M | -4.03M | -3.56M | -3.27M | -2.62M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | -0.01M | 0.01M | 0.00M | |||||||||||||||||||
| Non Operating Investment Income | |||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -547.00 | 0.00M | 0.00M | 0.01M | 0.05M | 0.11M | 0.15M | 0.10M | 0.09M | 0.06M | 0.17M | 0.09M | 0.05M | 0.05M | 0.09M | 0.02M | 0.06M | 0.14M | 0.09M | 0.18M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.20M | 0.28M | 0.09M | 0.18M | -0.00M | -0.46M | -0.01M | -0.46M | 0.14M | 0.07M | 0.46M | 0.20M | 0.07M | -0.01M | 0.06M | 0.01M | -0.03M | 0.04M | -0.00M | -0.00M | |||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.20M | 0.28M | 0.09M | 0.19M | 0.05M | -0.34M | 0.14M | -0.37M | 0.23M | 0.26M | 0.50M | 0.28M | 0.10M | 0.03M | 0.11M | 0.03M | 0.02M | 0.19M | 0.08M | 0.17M | |||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -2.28M | -3.71M | -7.36M | -5.33M | -3.51M | -12.08M | -6.85M | -11.70M | -11.33M | -9.42M | -7.43M | -7.85M | -8.37M | -6.25M | -6.43M | -6.05M | -4.01M | -3.45M | -3.19M | -2.45M | |||||||||||||
| Tax ProvisionsTaxes | 0.00M | 0.00M | 0.01M | 0.00M | -5.94M | 0.00M | 0.01M | 0.01M | -8.24M | 0.01M | 0.01M | -6.29M | 0.01M | 0.01M | 0.00M | -4.18M | 0.00M | 0.00M | |||||||||||||||
| Profit After TaxPAT | -2.30M | -3.68M | -7.37M | -5.34M | -5.45M | -9.28M | -6.90M | -11.71M | -11.35M | -9.39M | -7.43M | -7.90M | -8.40M | -6.22M | -6.43M | -6.10M | -4.01M | -3.40M | -3.20M | -2.45M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -2.28M | -3.71M | -7.37M | -5.34M | -3.52M | -6.14M | -6.85M | -11.71M | -11.35M | -1.18M | -7.43M | -7.86M | -8.37M | 0.04M | -6.43M | -6.05M | -4.01M | 0.73M | -3.20M | -2.45M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -2.28M | -3.71M | -7.37M | -5.34M | -3.52M | -6.14M | -6.85M | -11.71M | -11.35M | -1.18M | -7.43M | -7.86M | -8.37M | 0.04M | -6.43M | -6.05M | -4.01M | 0.73M | -3.20M | -2.45M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -2.28M | -3.71M | -7.37M | -5.34M | -3.52M | -6.14M | -6.85M | -11.71M | -11.35M | -1.18M | -7.43M | -7.86M | -8.37M | 0.04M | -6.43M | -6.05M | -4.01M | 0.73M | -3.20M | -2.45M | |||||||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -2.28M | -3.71M | -7.37M | -5.34M | -3.52M | -6.14M | -6.85M | -11.71M | -11.35M | -1.18M | -7.43M | -7.86M | -8.37M | 0.04M | -6.43M | -6.05M | -4.01M | 0.73M | -3.20M | -2.45M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -2.47 | -5.02 | -7.98 | -5.78 | -3.65 | -6.29 | -6.28 | -10.44 | -9.44 | -0.99 | -4.97 | -5.14 | -4.95 | 0.02 | -2.64 | -2.43 | -1.10 | 0.20 | -0.46 | -0.19 | |||||||||||||
| Shares Outstanding | 0.92M | 0.74M | 0.92M | 0.92M | 0.96M | 0.98M | 1.09M | 1.12M | 1.20M | 1.19M | 1.49M | 1.53M | 1.69M | 1.66M | 2.43M | 2.49M | 3.63M | 3.63M | 7.02M | 13.21M | |||||||||||||
| EBITDA | -2.48M | -3.96M | -7.45M | -5.52M | -5.50M | -8.89M | -6.98M | -11.34M | -11.56M | -9.62M | -7.92M | -8.13M | -8.46M | -6.28M | -6.54M | -6.07M | -4.03M | -3.56M | -3.27M | -2.62M | |||||||||||||
| Interest ExpensesInt Expense | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.01M | 0.01M | 0.00M | 0.01M | 0.00M | 0.00M | -0.01M | 0.01M | 0.00M | |||||||||||||||||||
| Tax Rate | -0.09 | -0.05 | -0.13 | -0.05 | 49.19 | -0.04 | -0.06 | -0.11 | 87.51 | -0.10 | -0.09 | 100.62 | -0.08 | -0.13 | -0.07 | 121.16 | -0.10 | -0.11 |